152 related articles for article (PubMed ID: 1564837)
21. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
Ogawa O; Yoshimura N; Taniguchi T; Nishimura K; Nakagawa T
Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338
[TBL] [Abstract][Full Text] [Related]
23. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
Loehrer PJ; Einhorn LH; Elson PJ; Crawford ED; Kuebler P; Tannock I; Raghavan D; Stuart-Harris R; Sarosdy MF; Lowe BA
J Clin Oncol; 1992 Jul; 10(7):1066-73. PubMed ID: 1607913
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
Wei CH; Hsieh RK; Chiou TJ; Chen KK; Chang LS; Chen PM
J Urol; 1996 Jan; 155(1):118-21. PubMed ID: 7490806
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of paclitaxel and cisplatin for advanced urothelial cancer.
Burch PA; Richardson RL; Cha SS; Sargent DJ; Pitot HC; Kaur JS; Camoriano JK
J Urol; 2000 Nov; 164(5):1538-42. PubMed ID: 11025699
[TBL] [Abstract][Full Text] [Related]
27. [Chemotherapy of invasive bladder cancer].
Kotake T
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2375-82. PubMed ID: 1952956
[TBL] [Abstract][Full Text] [Related]
28. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
[TBL] [Abstract][Full Text] [Related]
29. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
[TBL] [Abstract][Full Text] [Related]
30. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y
Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy with sequential methotrexate and 5-fluorouracil scheduling, epirubicin and cisplatin for locally advanced bladder cancer.
Nishiyama T; Tanikawa T; Tomita Y; Takahasi K
Oncology; 2002; 63(1):1-5. PubMed ID: 12187064
[TBL] [Abstract][Full Text] [Related]
32. Intra-arterial administration of methotrexate, adriamycin, and cisplatin as neoadjuvant chemotherapy for bladder cancer.
Kuriyama M; Takahashi Y; Nagatani Y; Shinoda I; Yamamoto N; Nagai T; Ueno K; Takeuchi T; Maeda S; Isogai K
Cancer Chemother Pharmacol; 1992; 30 Suppl():S1-4. PubMed ID: 1394808
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
Czito B; Zietman A; Kaufman D; Skowronski U; Shipley W
J Urol; 2004 Oct; 172(4 Pt 1):1271-5. PubMed ID: 15371822
[TBL] [Abstract][Full Text] [Related]
34. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
Konami T; Wakabayashi Y; Kim T; Ishida A; Arai Y; Konishi T; Pak K; Takeuchi H; Tomoyoshi T; Watanabe J
Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic experience of advanced urothelial tract tumors.
Nakada T; Akiya T; Yoshikawa M; Umeda K; Katayama T
Hinyokika Kiyo; 1985 Apr; 31(4):601-6. PubMed ID: 4041118
[TBL] [Abstract][Full Text] [Related]
36. [Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].
Takahashi Y; Yamamoto N; Deguchi T; Kuriyama M; Yoh M; Yasuda M; Nakano M; Kawada Y; Takeuchi T; Shinoda I
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1310-3. PubMed ID: 9703815
[TBL] [Abstract][Full Text] [Related]
37. Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial.
Loehrer PJ; Elson P; Dreicer R; Hahn R; Nichols CR; Williams R; Einhorn LH
J Clin Oncol; 1994 Mar; 12(3):483-8. PubMed ID: 7509853
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].
Hattori Y; Takizawa A; Kishida T; Kakizoe M; Fujikawa N; Teranishi J; Kondo K; Saito K; Noguchi K; Nakaigawa N; Kubota Y
Gan To Kagaku Ryoho; 2007 May; 34(5):739-43. PubMed ID: 17496448
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial.
Pectasides D; Visvikis A; Aspropotamitis A; Halikia A; Karvounis N; Dimitriadis M; Athanassiou A
Eur J Cancer; 2000 Jan; 36(1):74-9. PubMed ID: 10741298
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.
Kitamura H; Taguchi K; Kunishima Y; Yanase M; Takahashi A; Shigyo M; Tanaka T; Mutoh M; Fukuta F; Masumori N; Tsukamoto T
Cancer Sci; 2011 Jun; 102(6):1171-5. PubMed ID: 21323791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
